Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microtubule-Targeting Drugs: More than Antimitotics
Roma Kaul, April L. Risinger, Susan L. Mooberry
Journal of Natural Products (2019) Vol. 82, Iss. 3, pp. 680-685
Closed Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

Rosmarinic Acid Exhibits Anticancer Effects via MARK4 Inhibition
Saleha Anwar, Anas Shamsi, Mohd Shahbaaz, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 145
Ellagic Acid Controls Cell Proliferation and Induces Apoptosis in Breast Cancer Cells via Inhibition of Cyclin-Dependent Kinase 6
Mohd Yousuf, Anas Shamsi, Parvez Κhan, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3526-3526
Open Access | Times Cited: 93
Discovery of Hordenine as a Potential Inhibitor of Pyruvate Dehydrogenase Kinase 3: Implication in Lung Cancer Therapy
Saleha Anwar, Taj Mohammad, Anas Shamsi, et al.
Biomedicines (2020) Vol. 8, Iss. 5, pp. 119-119
Open Access | Times Cited: 86
Design, Synthesis, and Biological Evaluation of Heterocyclic-Fused Pyrimidine Chemotypes Guided by X-ray Crystal Structure with Potential Antitumor and Anti-multidrug Resistance Efficacy Targeting the Colchicine Binding Site
Lun Tan, Chengyong Wu, Jifa Zhang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 5, pp. 3588-3620
Closed Access | Times Cited: 24
The microtubule cytoskeleton: A validated target for the development of 2-Aryl-1H-benzo[d]imidazole derivatives as potential anticancer agents
Su Jeong Park, In‐ho Song, Gyu Seong Yeom, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116106-116106
Open Access | Times Cited: 10
Identification of α-Mangostin as a Potential Inhibitor of Microtubule Affinity Regulating Kinase 4
Parvez Κhan, Aarfa Queen, Taj Mohammad, et al.
Journal of Natural Products (2019) Vol. 82, Iss. 8, pp. 2252-2261
Closed Access | Times Cited: 74
Synthesis, biological evaluation, and molecular docking analysis of phenstatin based indole linked chalcones as anticancer agents and tubulin polymerization inhibitors
Jyoti Kode, Jeshma Kovvuri, Burri Nagaraju, et al.
Bioorganic Chemistry (2020) Vol. 105, pp. 104447-104447
Closed Access | Times Cited: 66
Pharmacology of apocynin: a natural acetophenone
Shreya R. Savla, Ankit P. Laddha, Yogesh A. Kulkarni
Drug Metabolism Reviews (2021) Vol. 53, Iss. 4, pp. 542-562
Closed Access | Times Cited: 54
Structural insights into the mechanism of GTP initiation of microtubule assembly
Ju Zhou, Anhui Wang, Yinlong Song, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Synthesis of New Thiazole-Privileged Chalcones as Tubulin Polymerization Inhibitors with Potential Anticancer Activities
Hamada Hashem, Abdelfattah Hassan, Walid M. Abdelmagid, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1154-1154
Open Access | Times Cited: 7
Exploiting immune-dependent effects of microtubule-targeting agents to improve efficacy and tolerability of cancer treatment
Angela Flavia Serpico, Roberta Visconti, Domenico Grieco
Cell Death and Disease (2020) Vol. 11, Iss. 5
Open Access | Times Cited: 49
Targeting Autophagy with Natural Products as a Potential Therapeutic Approach for Cancer
Md. Abdul Alim Al‐Bari, Yuko Ito, Samrein B. M. Ahmed, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9807-9807
Open Access | Times Cited: 35
Fluorinated benzylidene indanone exhibits antiproliferative activity through modulation of microtubule dynamics and antiangiogenic activity
Ankita Srivastava, Kaneez Fatima, Eram Fatima, et al.
European Journal of Pharmaceutical Sciences (2020) Vol. 154, pp. 105513-105513
Closed Access | Times Cited: 39
Topology Protects Chiral Edge Currents in Stochastic Systems
Evelyn Tang, Jaime Agudo‐Canalejo, Ramin Golestanian
Physical Review X (2021) Vol. 11, Iss. 3
Open Access | Times Cited: 28
Eribulin Activates the cGAS-STING Pathway via the Cytoplasmic Accumulation of Mitochondrial DNA
Charles S. Fermaintt, Leila Takahashi‐Ruiz, Huiyun Liang, et al.
Molecular Pharmacology (2021) Vol. 100, Iss. 4, pp. 309-318
Open Access | Times Cited: 28
βIII-tubulin overexpression in cancer: Causes, consequences, and potential therapies
Arun Kanakkanthara, John H. Miller
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188607-188607
Open Access | Times Cited: 28
Cyanobacteria: A Promising Source of Antifungal Metabolites
Samuel Cavalcante do Amaral, Luciana Pereira Xavier, Vı́tor Vasconcelos, et al.
Marine Drugs (2023) Vol. 21, Iss. 6, pp. 359-359
Open Access | Times Cited: 11
Progress in the discovery and development of anticancer agents from marine cyanobacteria
Hendrik Luesch, Emma K. Ellis, Qi-Yin Chen, et al.
Natural Product Reports (2024)
Open Access | Times Cited: 4
A Review of epidemiology, diagnosis, and management of Mpox: The role of One Health
Chien-Yuan Huang, Shih-Bin Su, Kow‐Tong Chen
Global Health & Medicine (2025) Vol. 7, Iss. 1, pp. 1-12
Closed Access
Discovery of a novel microtubule destabilizing agent targeting the colchicine site based on molecular docking
Jinhui Cai, Miao He, Yingying Wang, et al.
Biochemical Pharmacology (2025) Vol. 234, pp. 116804-116804
Closed Access
Endophytic fungi in anticancer drug development: Targeting tumor microenvironment
Yogesh Kumar, Lokesh Gambhir, Gaurav Sharma, et al.
Elsevier eBooks (2025), pp. 75-107
Closed Access
Novel insights into taxane pharmacology: an update on drug resistance mechanisms, immunomodulation and drug delivery strategies
Giovanni Luca Beretta, Giuliana Cassinelli, Giacomina Rossi, et al.
Drug Resistance Updates (2025) Vol. 81, pp. 101223-101223
Open Access
Recent developments of benzimidazole based analogs as potential tubulin polymerization inhibitors: A critical review
Rajkumar Reddyrajula, K Priya Varshini, Nagula Shankaraiah
Bioorganic & Medicinal Chemistry Letters (2025), pp. 130167-130167
Closed Access
The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models
Leila Takahashi‐Ruiz, Charles S. Fermaintt, Nancy Wilkinson, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5962-5962
Open Access | Times Cited: 18
SB226, an inhibitor of tubulin polymerization, inhibits paclitaxel-resistant melanoma growth and spontaneous metastasis
Shanshan Deng, Souvik Banerjee, Hao Chen, et al.
Cancer Letters (2022) Vol. 555, pp. 216046-216046
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top